303 related articles for article (PubMed ID: 25793711)
21. Intragenic Variations in BTLA Gene Influence mRNA Expression of BTLA Gene in Chronic Lymphocytic Leukemia Patients and Confer Susceptibility to Chronic Lymphocytic Leukemia.
Karabon L; Partyka A; Jasek M; Lech-Maranda E; Grzybowska-Izydorczyk O; Bojarska-Junak A; Pawlak-Adamska E; Tomkiewicz A; Robak T; Rolinski J; Frydecka I
Arch Immunol Ther Exp (Warsz); 2016 Dec; 64(Suppl 1):137-145. PubMed ID: 27933341
[TBL] [Abstract][Full Text] [Related]
22. The prognostic impact of microRNA sequence polymorphisms on the recurrence of patients with completely resected non-small cell lung cancer.
Yoon KA; Yoon H; Park S; Jang HJ; Zo JI; Lee HS; Lee JS
J Thorac Cardiovasc Surg; 2012 Oct; 144(4):794-807. PubMed ID: 22818121
[TBL] [Abstract][Full Text] [Related]
23. MicroRNAs in chronic lymphocytic leukemia.
Ward BP; Tsongalis GJ; Kaur P
Exp Mol Pathol; 2011 Apr; 90(2):173-8. PubMed ID: 21168405
[TBL] [Abstract][Full Text] [Related]
24. Genomics of chronic lymphocytic leukemia microRNAs as new players with clinical significance.
Calin GA; Croce CM
Semin Oncol; 2006 Apr; 33(2):167-73. PubMed ID: 16616063
[TBL] [Abstract][Full Text] [Related]
25. Increased chronic lymphocytic leukemia proliferation upon IgM stimulation is sustained by the upregulation of miR-132 and miR-212.
Tavolaro S; Colombo T; Chiaretti S; Peragine N; Fulci V; Ricciardi MR; Messina M; Bonina S; Brugnoletti F; Marinelli M; Di Maio V; Mauro FR; Del Giudice I; Macino G; Foà R; Guarini A
Genes Chromosomes Cancer; 2015 Apr; 54(4):222-34. PubMed ID: 25645730
[TBL] [Abstract][Full Text] [Related]
26. A functional polymorphism in pre-microRNA-196a-2 contributes to the susceptibility of hepatocellular carcinoma in a Turkish population: a case-control study.
Akkız H; Bayram S; Bekar A; Akgöllü E; Ulger Y
J Viral Hepat; 2011 Jul; 18(7):e399-407. PubMed ID: 21692953
[TBL] [Abstract][Full Text] [Related]
27. Potentially functional genetic variants in microRNA processing genes and risk of HBV-related hepatocellular carcinoma.
Liu L; An J; Liu J; Wen J; Zhai X; Liu Y; Pan S; Jiang J; Wen Y; Liu Z; Zhang Y; Chen J; Xing J; Ji G; Shen H; Hu Z; Fan Z
Mol Carcinog; 2013 Nov; 52 Suppl 1():E148-54. PubMed ID: 23868705
[TBL] [Abstract][Full Text] [Related]
28. Polymorphisms in lipid metabolism related miRNA binding sites and risk of metabolic syndrome.
Ye Q; Zhao X; Xu K; Li Q; Cheng J; Gao Y; Du J; Shi H; Zhou L
Gene; 2013 Oct; 528(2):132-8. PubMed ID: 23911300
[TBL] [Abstract][Full Text] [Related]
29. MicroRNAs in the pathogeny of chronic lymphocytic leukaemia.
Nicoloso MS; Kipps TJ; Croce CM; Calin GA
Br J Haematol; 2007 Dec; 139(5):709-16. PubMed ID: 18021085
[TBL] [Abstract][Full Text] [Related]
30. Polymorphisms in human pre-miRNAs.
Iwai N; Naraba H
Biochem Biophys Res Commun; 2005 Jun; 331(4):1439-44. PubMed ID: 15883035
[TBL] [Abstract][Full Text] [Related]
31. Human diseases caused by germline and somatic abnormalities in microRNA and microRNA-related genes.
Kawahara Y
Congenit Anom (Kyoto); 2014 Feb; 54(1):12-21. PubMed ID: 24330020
[TBL] [Abstract][Full Text] [Related]
32. Critical role of microRNAs in chronic lymphocytic leukemia: overexpression of the oncogene PLAG1 by deregulated miRNAs.
Patz M; Pallasch CP; Wendtner CM
Leuk Lymphoma; 2010 Aug; 51(8):1379-81. PubMed ID: 20687796
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA genes are frequently located near mouse cancer susceptibility loci.
Sevignani C; Calin GA; Nnadi SC; Shimizu M; Davuluri RV; Hyslop T; Demant P; Croce CM; Siracusa LD
Proc Natl Acad Sci U S A; 2007 May; 104(19):8017-22. PubMed ID: 17470785
[TBL] [Abstract][Full Text] [Related]
34. miR-181a/b significantly enhances drug sensitivity in chronic lymphocytic leukemia cells via targeting multiple anti-apoptosis genes.
Zhu DX; Zhu W; Fang C; Fan L; Zou ZJ; Wang YH; Liu P; Hong M; Miao KR; Liu P; Xu W; Li JY
Carcinogenesis; 2012 Jul; 33(7):1294-301. PubMed ID: 22610076
[TBL] [Abstract][Full Text] [Related]
35. Role of signaling pathways and miRNAs in chronic lymphocytic leukemia.
Li PP; Wang X
Chin Med J (Engl); 2013 Nov; 126(21):4175-82. PubMed ID: 24229693
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA in chronic lymphocytic leukemia: transitioning from laboratory-based investigation to clinical application.
Nana-Sinkam SP; Croce CM
Cancer Genet Cytogenet; 2010 Dec; 203(2):127-33. PubMed ID: 21156224
[TBL] [Abstract][Full Text] [Related]
37. Regulation of the MIR155 host gene in physiological and pathological processes.
Elton TS; Selemon H; Elton SM; Parinandi NL
Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
[TBL] [Abstract][Full Text] [Related]
38. rs2072135, a low-penetrance variant for chronic lymphocytic leukaemia?
Sava GP; Speedy HE; Di Bernardo MC; Deaglio S; Karabon L; Frydecka I; Woszczyk D; Rossi D; Gaidano G; Mansouri L; Smedby KE; Juliusson G; Rosenquist R; Catovsky D; Houlston RS
Br J Haematol; 2013 Jul; 162(2):221-8. PubMed ID: 23668599
[TBL] [Abstract][Full Text] [Related]
39. The role of microRNA and other non-coding RNA in the pathogenesis of chronic lymphocytic leukemia.
Calin GA; Pekarsky Y; Croce CM
Best Pract Res Clin Haematol; 2007 Sep; 20(3):425-37. PubMed ID: 17707831
[TBL] [Abstract][Full Text] [Related]
40. SNP Variation in MicroRNA Biogenesis Pathway Genes as a New Innovation Strategy for Alzheimer Disease Diagnostics: A Study of 10 Candidate Genes in an Understudied Population From the Eastern Mediterranean.
Görücü Yilmaz Ş; Erdal ME; Avci Özge A; Sungur MA
Alzheimer Dis Assoc Disord; 2016; 30(3):203-9. PubMed ID: 26796812
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
